taurine has been researched along with Innate Inflammatory Response in 118 studies
Excerpt | Relevance | Reference |
---|---|---|
"Taurine improves endothelial function in CBS-deficient homocystinuria in patients with preexisting reduced function." | 9.30 | Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine β-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial. ( Christians, U; Cowan, TM; Creadon-Swindell, G; Emmett, P; Ficicioglu, C; Freehauf, CL; Friederich, MW; Harrington, MJ; Henthorn, TK; Hite, M; Jiang, H; Kronquist, KE; MacLean, KN; Moreau, KL; Pena, LDM; Pyle, L; Spector, EB; Stabler, SP; Thomas, JA; Van Hove, JLK; Wempe, MF; Young, SP, 2019) |
" Thus, we investigated the anti-inflammatory effect of exercise and taurine supplementation on peripheral markers of BBB, inflammation, and cognition of elderly women." | 9.27 | Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women. ( Chupel, MU; Filaire, E; Furtado, G; Hogervorst, E; Minuzzi, LG; Santos, ML; Teixeira, AM, 2018) |
"This study was conducted to explore the beneficial role of taurine against chronic high carbohydrate diet-induced oxidative stress, endoplasmic reticulum (ER) stress and inflammation, and to understand the underlying molecular mechanisms in turbot." | 8.02 | Dietary taurine modulates hepatic oxidative status, ER stress and inflammation in juvenile turbot (Scophthalmus maximus L.) fed high carbohydrate diets. ( Liu, D; Mai, K; Pan, M; Wei, Z; Wu, C; Yang, M; Zhang, W; Zhang, Y, 2021) |
"The protective effect of taurine against inflammation, apoptosis and oxidative stress in traumatic brain injury was investigated in the present study." | 7.88 | Protective effects of taurine against inflammation, apoptosis, and oxidative stress in brain injury. ( Li, S; Liu, H; Niu, X; Zheng, S, 2018) |
" Furthermore, we assessed the therapeutic effects of taurine on ovalbumin (OVA)-induced allergic rhinitis (AR) animal models." | 7.85 | The potential protective role of taurine against experimental allergic inflammation. ( Jeong, HJ; Kim, HM; Nam, SY, 2017) |
" Taurine protects cells from the cytotoxic effects of inflammation." | 7.83 | Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits. ( Kerry, Z; Ozgur, HH; Ozsarlak-Sozer, G; Sevin, G; Yetik-Anacak, G, 2016) |
"We observed no overall association between serum taurine and stroke risk, although a protective effect was observed in never smokers, which requires further investigation." | 7.83 | Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study. ( Afanasyeva, Y; Chen, Y; Costa, M; Jonas, S; Koenig, KL; Wójcik, OP; Wu, F; Zeleniuch-Jacquotte, A, 2016) |
"Our findings indicate that taurine treatment attenuates the infiltration of adipose tissue by macrophages and modulates the phenotype of macrophages, which suggest that taurine is a valuable food constituent with a potential to attenuate chronic inflammation in adipose tissue and improve obesity-related insulin resistance." | 7.79 | Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages. ( Goto, T; Hirai, S; Kawada, T; Lin, S; Murakami, S; Mutoh, C; Sakurai, T; Takahashi, N; Tani, F; Yamaguchi, Y; Yu, R, 2013) |
"Taurine is reported to reduce tissue damage induced by inflammation and to protect the brain against experimental stroke." | 7.78 | Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. ( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012) |
" PA and Tau effectively inhibited inflammation, edema, severity of fibrosis, fibrosis extension, inflammatory cell accumulation, iNOS staining, and hydroxyproline level as well (p < 0." | 7.78 | The efficiency of proanthocyanidin in an experimental pulmonary fibrosis model: comparison with taurine. ( Agackiran, Y; Akyurek, N; Gul, H; Gunay, E; Gunay, S; Ide, T; Memis, L; Sirin, YS, 2012) |
"Neutrophil elastase in the cystic fibrosis airways inhibits opsonophagocytosis and induces the expression of interleukin-8, a neutrophil chemoattractant." | 7.73 | Prolastin aerosol therapy and sputum taurine in cystic fibrosis. ( Berthiaume, Y; Cantin, AM; Cloutier, D; Martel, M, 2006) |
" This study evaluated the potential usefulness of supplementation of total parenteral nutrition with a cysteine, taurine, threonine, and serine mixture (SEAS), with or without glutamine, in an experimental model of turpentine-induced acute inflammation." | 7.72 | Efficiency of a cysteine-taurine-threonine-serine supplemented parenteral nutrition in an experimental model of acute inflammation. ( Bérard, MP; Chaïb, S; Cynober, L; De Bandt, JP; Neveux, N; Osowska, S, 2003) |
"Taurine is an intracellular free amino acid that has anti-inflammatory and antioxidant effects." | 5.72 | Mechanism of taurine reducing inflammation and organ injury in sepsis mice. ( Deng, S; Hao, Y; Li, R; Ma, Y; Qin, Q; Ran, C; Zhang, J; Zhang, Y; Zhu, L, 2022) |
"Lung injury is a significant complication associated with cholestasis/cirrhosis." | 5.72 | Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation. ( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022) |
" Chronic administration of taurine attenuated STZ-induced cognitive impairment." | 5.46 | Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. ( Gupta, YK; Reeta, KH; Singh, D, 2017) |
"Taurine pretreatment also reduced the elevated expression levels of LPS‑induced cyclooxygenase‑2, nuclear factor κB and extracellular regulated protein kinase." | 5.46 | Taurine alleviates lipopolysaccharide‑induced liver injury by anti‑inflammation and antioxidants in rats. ( Li, F; Liu, Y; Wang, Y; Wu, J; Yu, H; Zhang, L, 2017) |
"Maternal obesity is associated with obesity and metabolic disorders in offspring." | 5.39 | Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. ( Gray, C; Li, M; Reynolds, CM; Sloboda, DM; Vickers, MH, 2013) |
"Taurine has been shown to protect against lung injury induced by various oxidants including ozone, nitrogen dioxide, amiodarone, and paraquat and to protect against bleomycin-induced lung injury in combination with niacin." | 5.35 | Protection of bleomycin-induced fibrosis and inflammation by taurine. ( Gordon, RE; Park, E; Park, SY; Schuller-Levis, G; Wang, C, 2009) |
"Taurine improves endothelial function in CBS-deficient homocystinuria in patients with preexisting reduced function." | 5.30 | Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine β-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial. ( Christians, U; Cowan, TM; Creadon-Swindell, G; Emmett, P; Ficicioglu, C; Freehauf, CL; Friederich, MW; Harrington, MJ; Henthorn, TK; Hite, M; Jiang, H; Kronquist, KE; MacLean, KN; Moreau, KL; Pena, LDM; Pyle, L; Spector, EB; Stabler, SP; Thomas, JA; Van Hove, JLK; Wempe, MF; Young, SP, 2019) |
"The practice of prolonged exercise with high intensity, as seen in triathlon training, can cause physiological imbalances that might result in muscle fatigue, muscle damage and changes in systemic inflammatory response, thus reduce the athletes' physical performance, therefore, both adequate total caloric and macronutrient intake also the use of a specific ergogenic aid, as taurine supplementation would be an alternative to prevent inflammation and muscle damage." | 5.27 | Effects of taurine on markers of muscle damage, inflammatory response and physical performance in triathletes. ( Carvalho, FG; da Silva, AS; Freitas, EC; Galan, BS; Gobbi, RB; Kalva-Filho, CA; Papoti, M; Santos, PC, 2018) |
" Thus, we investigated the anti-inflammatory effect of exercise and taurine supplementation on peripheral markers of BBB, inflammation, and cognition of elderly women." | 5.27 | Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women. ( Chupel, MU; Filaire, E; Furtado, G; Hogervorst, E; Minuzzi, LG; Santos, ML; Teixeira, AM, 2018) |
"Amelioration of both oxidative and inflammation status after cholesterol lowering treatment in CKD might be mediated by restoration of antioxidant taurine concentrations during therapy (from 51." | 5.20 | Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement. ( Carru, C; Mangoni, AA; Sanna, M; Satta, AE; Sotgia, S; Zinellu, A, 2015) |
"The purpose of the present study was to investigate the effects of taurine supplementation on muscle performance, oxidative stress, and inflammation response after eccentric exercise (EE) in males." | 5.19 | Effects of taurine supplementation following eccentric exercise in young adults. ( Bom, KF; Cassiano, W; da Luz, G; da Rosa, GL; da Silva, LA; De Souza, CT; Mariano, I; Petronilho, F; Pinho, RA; Pozzi, B; Tromm, CB; Tuon, T; Vuolo, F, 2014) |
"Taurine chloramine (TauCl) is generated at the site of inflammation as a result of reaction of taurine with hypochlorous acid (HOCl), the product of myeloperoxidase-halide system of neutrophils." | 4.87 | [Taurine chloramine and its potential therapeutical application]. ( Marcinkiewicz, J; Walczewska, M, 2011) |
" It plays a key role in the metabolic pathways involving methionine, taurine and glutathione (GSH), and may help fight chronic inflammation by boosting antioxidant status." | 4.87 | Clinical and nutritional benefits of cysteine-enriched protein supplements. ( Hardy, G; McPherson, RA, 2011) |
"On the 3rd day, taurine and apocynin prevented inflammation, the effects of taurine in the zone of stasis in the early period (7th day) are more pronounced, the effect of apocynin on antioxidant enzymes is more pronounced." | 4.12 | Effects of taurine and apocynin on the zone of stasis. ( Abbas Ali Noma, S; Fırat, C; Öcük, Ö; Özhan, O; Parlakpınar, H; Ulu, A; Vardı, N; Yıldız, A, 2022) |
"The aim of the present study is to examine the potential effect of dexamethasone (DEX) and taurine (TAU) on endoplasmic reticular stress (ERS) and inflammation." | 4.12 | Synergism Between Taurine and Dexamethasone in Anti-inflammatory Response in LPS-Activated Macrophages. ( Do, CH; Lee, DH, 2022) |
"This study was conducted to explore the beneficial role of taurine against chronic high carbohydrate diet-induced oxidative stress, endoplasmic reticulum (ER) stress and inflammation, and to understand the underlying molecular mechanisms in turbot." | 4.02 | Dietary taurine modulates hepatic oxidative status, ER stress and inflammation in juvenile turbot (Scophthalmus maximus L.) fed high carbohydrate diets. ( Liu, D; Mai, K; Pan, M; Wei, Z; Wu, C; Yang, M; Zhang, W; Zhang, Y, 2021) |
" The present study assessed the ability of taurine (TAU) to alleviate or prevent AMK-induced nephrotoxicity if co-administrated with AMK focusing on inflammation, apoptosis, and fibrosis." | 4.02 | The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation. ( Azmy, A; El-Amir, A; Madbouly, N; Salama, A, 2021) |
"The protective effect of taurine against inflammation, apoptosis and oxidative stress in traumatic brain injury was investigated in the present study." | 3.88 | Protective effects of taurine against inflammation, apoptosis, and oxidative stress in brain injury. ( Li, S; Liu, H; Niu, X; Zheng, S, 2018) |
" Furthermore, we assessed the therapeutic effects of taurine on ovalbumin (OVA)-induced allergic rhinitis (AR) animal models." | 3.85 | The potential protective role of taurine against experimental allergic inflammation. ( Jeong, HJ; Kim, HM; Nam, SY, 2017) |
" Importantly, angiotensin II (AngII), independently of its vasoconstrictor action, causes β-cell inflammation and dysfunction, which may be an early step in the development of type 2 diabetes." | 3.85 | Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response. ( Chan, SMH; Herbert, TP; Ku, JM; Lau, YS; Miller, AA; Potocnik, S; Woodman, OL; Ye, JM, 2017) |
" Taurine protects cells from the cytotoxic effects of inflammation." | 3.83 | Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits. ( Kerry, Z; Ozgur, HH; Ozsarlak-Sozer, G; Sevin, G; Yetik-Anacak, G, 2016) |
"We observed no overall association between serum taurine and stroke risk, although a protective effect was observed in never smokers, which requires further investigation." | 3.83 | Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study. ( Afanasyeva, Y; Chen, Y; Costa, M; Jonas, S; Koenig, KL; Wójcik, OP; Wu, F; Zeleniuch-Jacquotte, A, 2016) |
"At the sites of inflammation, hypohalous acids, such as hypochlorous acid and hypobromous acid (HOBr), are produced by myeloperoxidase." | 3.81 | Specific role of taurine in the 8-brominated-2'-deoxyguanosine formation. ( Asahi, T; Kato, Y; Nakamura, Y; Osawa, T, 2015) |
"Our findings indicate that taurine treatment attenuates the infiltration of adipose tissue by macrophages and modulates the phenotype of macrophages, which suggest that taurine is a valuable food constituent with a potential to attenuate chronic inflammation in adipose tissue and improve obesity-related insulin resistance." | 3.79 | Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages. ( Goto, T; Hirai, S; Kawada, T; Lin, S; Murakami, S; Mutoh, C; Sakurai, T; Takahashi, N; Tani, F; Yamaguchi, Y; Yu, R, 2013) |
"Taurine is reported to reduce tissue damage induced by inflammation and to protect the brain against experimental stroke." | 3.78 | Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. ( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012) |
"This pilot study aimed to determine the efficacy of acamprosate (N-acetyl homotaurine) in reducing the pathological features of experimental autoimmune encephalomyelitis (EAE) which is an animal model for multiple sclerosis (MS)." | 3.78 | Acamprosate modulates experimental autoimmune encephalomyelitis. ( Cesario, A; Leung, YK; Munschauer, FE; Pankewycz, O; Rittenhouse-Olson, K; Sobel, RA; Sternberg, DS; Sternberg, Z; Whitcomb, T; Zhu, B, 2012) |
" PA and Tau effectively inhibited inflammation, edema, severity of fibrosis, fibrosis extension, inflammatory cell accumulation, iNOS staining, and hydroxyproline level as well (p < 0." | 3.78 | The efficiency of proanthocyanidin in an experimental pulmonary fibrosis model: comparison with taurine. ( Agackiran, Y; Akyurek, N; Gul, H; Gunay, E; Gunay, S; Ide, T; Memis, L; Sirin, YS, 2012) |
"Our results indicate that taurine has protective effects on hyperhomocysteinemia-induced toxicity by decreasing oxidative and nitrosative stresses, apoptosis, and necrosis in the liver." | 3.75 | Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine. ( Doğru-Abbasoğlu, S; Giriş, M; Olgaç, V; Unlüçerçi, Y; Uysal, M; Yalçinkaya, S, 2009) |
"Neutrophil elastase in the cystic fibrosis airways inhibits opsonophagocytosis and induces the expression of interleukin-8, a neutrophil chemoattractant." | 3.73 | Prolastin aerosol therapy and sputum taurine in cystic fibrosis. ( Berthiaume, Y; Cantin, AM; Cloutier, D; Martel, M, 2006) |
"In this study, in an animal model of zymosan-induced peritonitis we have tested anti-inflammatory properties of Taurolidine (TRD), a synthetic derivative of taurine." | 3.73 | Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms. ( Biedroń, R; Bobek, M; Kontny, E; Kurnyta, M; Marcinkiewicz, J; Maśliński, W, 2006) |
" This study evaluated the potential usefulness of supplementation of total parenteral nutrition with a cysteine, taurine, threonine, and serine mixture (SEAS), with or without glutamine, in an experimental model of turpentine-induced acute inflammation." | 3.72 | Efficiency of a cysteine-taurine-threonine-serine supplemented parenteral nutrition in an experimental model of acute inflammation. ( Bérard, MP; Chaïb, S; Cynober, L; De Bandt, JP; Neveux, N; Osowska, S, 2003) |
"The effect of in-vivo administration of N-2-hydroxyethylpiperazine-N'-2- ethane sulphonic acid (HEPES) and taurine on rat paw oedema and reactive oxidant production was examined." | 3.69 | Effects of in-vivo administration of taurine and HEPES on the inflammatory response in rats. ( Bloomfield, FJ; Mahon, TM; Nowlan, P; Stapleton, PP, 1994) |
"Combined treatment with taurine and niacin suppressed BL-induced inflammation and almost completely abrogated pulmonary fibrosis in hamsters." | 3.68 | Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin. ( Giri, SN; Hyde, DM; Wang, Q, 1992) |
"Peri-operative inflammation has been extensively highlighted in cancer patients as detrimental." | 2.87 | RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial. ( Foley, N; Jinih, M; Neary, PM; O'Connell, E; O'Leary, DP; Pfirrmann, RW; Redmond, HP; Wang, JH, 2018) |
" Non-linear relationship between variables and effect size was performed using dose-response and time-response analyses." | 2.82 | Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials. ( Faghfouri, AH; Faghfuri, E; Fathollahi, P; Ostadrahimi, A; Papi, S; Seyyed Shoura, SM; Shadbad, MA, 2022) |
"Taurine has become a popular supplement among athletes attempting to improve performance." | 2.72 | Taurine in sports and exercise. ( Doyle, JA; Kurtz, JA; Otis, JS; VanDusseldorp, TA, 2021) |
"Hyperlipidemia, an independent risk factor for atherosclerosis, is regarded as a lipid metabolism disorder associated with elevated plasma triglyceride and/or cholesterol." | 2.72 | The molecular targets of taurine confer anti-hyperlipidemic effects. ( Dong, Y; Gao, J; Li, X; Liu, Y; Tao, J, 2021) |
"Taurine is a non-protein amino acid that is expressed in the majority of animal tissues." | 2.66 | The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease. ( Abraham, JR; Apostolopoulos, V; Gadanec, LK; McSweeney, KR; Qaradakhi, T; Zulli, A, 2020) |
"Glycine has been well characterized in spinal cord as an inhibitory neurotransmitter which activates a glycine-gated chloride channel (GlyR) expressed in postsynaptic membranes." | 2.40 | Glycine: a new anti-inflammatory immunonutrient. ( Bradford, B; Enomoto, N; Ikejema, K; Rose, ML; Rusyn, I; Schemmer, P; Seabra, V; Stacklewitz, RF; Thurman, RG; Wheeler, MD; Yin, M; Zhong, Z, 1999) |
"Lung injury is a significant complication associated with cholestasis/cirrhosis." | 1.72 | Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation. ( Abdoli, N; Azarpira, N; Heidari, R; Lu, Y; Ma, Y; Manthari, RK; Mazloomi, S; Mehrabani, PS; Mingyu, Y; Mobasheri, A; Mousavifaraz, A; Nadgaran, A; Niknahad, H; Nikoozadeh, A; Ommati, MM; Rezaei, M; Sadeghian, I; Tang, Z; Xin, H; Xu, D, 2022) |
"Taurine was identified as an important metabolite may modulate human cervical smooth muscle cells." | 1.72 | Metabonomics profile analysis in inflammation-induced preterm birth and the potential role of metabolites in regulating premature cervical ripening. ( Bian, Z; Gu, Z; Guo, X; Li, B; Qiu, J; Yan, Y; Zhang, R; Zhang, Z, 2022) |
"Taurine is an intracellular free amino acid that has anti-inflammatory and antioxidant effects." | 1.72 | Mechanism of taurine reducing inflammation and organ injury in sepsis mice. ( Deng, S; Hao, Y; Li, R; Ma, Y; Qin, Q; Ran, C; Zhang, J; Zhang, Y; Zhu, L, 2022) |
"Taurine (Tau) is a kind of semi-essential β amino acid, and beneficial for β cell function." | 1.51 | Inorganic arsenic induces pyroptosis and pancreatic β cells dysfunction through stimulating the IRE1α/TNF-α pathway and protective effect of taurine. ( Gao, N; Jia, X; Jiang, L; Liu, S; Liu, X; Pei, P; Qiu, T; Sun, X; Tao, Y; Wang, N; Wang, Z; Wei, S; Yang, G; Yang, L; Yao, X, 2019) |
"Inflammation is a key contributor to the pathology of nonalcoholic fatty liver disease (NAFLD), including NASH." | 1.48 | Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway. ( Bai, J; Gao, N; Jiang, L; Liu, X; Pei, P; Qi, S; Qiu, T; Sun, X; Wang, Z; Wei, S; Yan, R; Yang, G; Yang, L; Yao, X, 2018) |
"Osteoarthritis is a type of joint disease that results from the breakdown of joint cartilage and underlying bone and is believed to be caused by mechanical stress on the joint and low-grade inflammatory processes." | 1.48 | Acamprosate Protects Against Adjuvant-Induced Arthritis in Rats via Blocking the ERK/MAPK and NF-κB Signaling Pathway. ( Jin, R; Pan, J; Shen, M; Wu, R; Xu, S, 2018) |
"Taurine pretreatment also reduced the elevated expression levels of LPS‑induced cyclooxygenase‑2, nuclear factor κB and extracellular regulated protein kinase." | 1.46 | Taurine alleviates lipopolysaccharide‑induced liver injury by anti‑inflammation and antioxidants in rats. ( Li, F; Liu, Y; Wang, Y; Wu, J; Yu, H; Zhang, L, 2017) |
" Chronic administration of taurine attenuated STZ-induced cognitive impairment." | 1.46 | Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation. ( Gupta, YK; Reeta, KH; Singh, D, 2017) |
"Maternal obesity is associated with obesity and metabolic disorders in offspring." | 1.39 | Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. ( Gray, C; Li, M; Reynolds, CM; Sloboda, DM; Vickers, MH, 2013) |
"Taurine was without effect." | 1.37 | Taurine chloramine inhibits NO and TNF-α production in zymosan plus interferon-γ activated RAW 264.7 cells. ( Cho, IS; Kim, BS; Levis, W; Park, E; Park, SY; Schuller-Levis, G, 2011) |
"Taurine was injected intraperitoneally at doses of 25, 80, 250, and 800 mg/kg within 30 min after SCI." | 1.36 | Taurine reduces inflammatory responses after spinal cord injury. ( Gupta, RC; Hara, M; Nakajima, Y; Osuka, K; Seki, Y; Takayasu, M; Wakabayashi, T, 2010) |
"Taurine has been shown to protect against lung injury induced by various oxidants including ozone, nitrogen dioxide, amiodarone, and paraquat and to protect against bleomycin-induced lung injury in combination with niacin." | 1.35 | Protection of bleomycin-induced fibrosis and inflammation by taurine. ( Gordon, RE; Park, E; Park, SY; Schuller-Levis, G; Wang, C, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.69) | 18.7374 |
1990's | 9 (7.63) | 18.2507 |
2000's | 21 (17.80) | 29.6817 |
2010's | 59 (50.00) | 24.3611 |
2020's | 27 (22.88) | 2.80 |
Authors | Studies |
---|---|
Saunders, MJ | 1 |
Edwards, BS | 1 |
Zhu, J | 1 |
Sklar, LA | 1 |
Graves, SW | 1 |
Faghfouri, AH | 1 |
Seyyed Shoura, SM | 1 |
Fathollahi, P | 1 |
Shadbad, MA | 1 |
Papi, S | 1 |
Ostadrahimi, A | 1 |
Faghfuri, E | 1 |
Li, M | 2 |
Wang, Z | 3 |
Qiu, Y | 1 |
Fu, S | 1 |
Xu, Y | 1 |
Han, X | 1 |
Phouthapane, V | 1 |
Miao, J | 2 |
Zhuang, Z | 1 |
Li, N | 2 |
Wang, J | 2 |
Yang, R | 1 |
Wang, W | 2 |
Liu, Z | 1 |
Huang, T | 1 |
Öcük, Ö | 1 |
Fırat, C | 1 |
Yıldız, A | 1 |
Vardı, N | 1 |
Ulu, A | 1 |
Abbas Ali Noma, S | 1 |
Parlakpınar, H | 1 |
Özhan, O | 1 |
Ma, Y | 2 |
Zhang, Y | 3 |
Li, R | 1 |
Deng, S | 1 |
Qin, Q | 1 |
Ran, C | 1 |
Hao, Y | 1 |
Zhang, J | 4 |
Zhu, L | 1 |
Do, CH | 1 |
Lee, DH | 1 |
Kim, HJ | 1 |
Kang, IS | 1 |
Kim, C | 7 |
Shi, Y | 1 |
Zhong, L | 1 |
Fan, Y | 1 |
Dai, J | 1 |
Zhong, H | 1 |
Fu, G | 1 |
Hu, Y | 1 |
Yan, Y | 1 |
Gu, Z | 1 |
Li, B | 1 |
Guo, X | 1 |
Zhang, Z | 1 |
Zhang, R | 1 |
Bian, Z | 1 |
Qiu, J | 1 |
Ommati, MM | 1 |
Mobasheri, A | 1 |
Xu, D | 1 |
Tang, Z | 2 |
Manthari, RK | 1 |
Abdoli, N | 1 |
Azarpira, N | 1 |
Lu, Y | 2 |
Sadeghian, I | 1 |
Mousavifaraz, A | 1 |
Nadgaran, A | 1 |
Nikoozadeh, A | 1 |
Mazloomi, S | 1 |
Mehrabani, PS | 1 |
Rezaei, M | 1 |
Xin, H | 1 |
Mingyu, Y | 1 |
Niknahad, H | 1 |
Heidari, R | 1 |
Ji, X | 1 |
Zhang, F | 1 |
Zhou, F | 1 |
Wu, Y | 1 |
Wu, D | 1 |
Reikvam, H | 1 |
Bruserud, Ø | 1 |
Hatfield, KJ | 1 |
Busı, MC | 1 |
Yigitaslan, S | 1 |
Kaltus, Z | 1 |
Harmancı, N | 1 |
Eroglu, E | 1 |
Ozatık, O | 1 |
Kaya, C | 1 |
Martins, N | 1 |
Magalhães, R | 1 |
Castro, C | 1 |
Couto, A | 1 |
Díaz-Rosales, P | 1 |
Oliva-Teles, A | 1 |
Peres, H | 1 |
Lee, H | 1 |
Lee, DS | 1 |
Chang, KJ | 1 |
Kim, SH | 3 |
Cheong, SH | 1 |
Zang, L | 1 |
Song, Y | 1 |
Yu, F | 1 |
Liu, X | 3 |
He, Y | 1 |
Yang, Z | 1 |
Li, J | 2 |
Li, E | 1 |
Jiménez Hernández, M | 1 |
Soriano, A | 2 |
Filella, X | 1 |
Calvo, M | 1 |
Coll, E | 1 |
Rebled, JM | 1 |
Poch, E | 1 |
Graterol, F | 1 |
Compte, MT | 1 |
Maduell, F | 2 |
Fontsere, N | 2 |
Baliou, S | 1 |
Kyriakopoulos, AM | 1 |
Spandidos, DA | 1 |
Zoumpourlis, V | 1 |
Han, H | 1 |
Chen, Y | 2 |
Shen, M | 2 |
Yan, E | 1 |
Wei, C | 1 |
Yu, C | 1 |
Zhang, L | 3 |
Wang, T | 1 |
Qaradakhi, T | 1 |
Gadanec, LK | 1 |
McSweeney, KR | 1 |
Abraham, JR | 1 |
Apostolopoulos, V | 1 |
Zulli, A | 1 |
Barbiera, A | 1 |
Sorrentino, S | 1 |
Lepore, E | 1 |
Carfì, A | 1 |
Sica, G | 1 |
Dobrowolny, G | 1 |
Scicchitano, BM | 1 |
Wei, Z | 1 |
Yang, M | 1 |
Liu, D | 2 |
Pan, M | 1 |
Wu, C | 1 |
Zhang, W | 1 |
Mai, K | 1 |
Iwegbulem, O | 1 |
Pfirrmann, RW | 2 |
Redmond, HP | 3 |
Dong, Y | 1 |
Li, X | 1 |
Liu, Y | 2 |
Gao, J | 1 |
Tao, J | 1 |
Kurtz, JA | 1 |
VanDusseldorp, TA | 1 |
Doyle, JA | 1 |
Otis, JS | 1 |
Lee, CC | 1 |
Chen, WT | 1 |
Chen, SY | 1 |
Lee, TM | 1 |
Madbouly, N | 1 |
Azmy, A | 1 |
Salama, A | 1 |
El-Amir, A | 1 |
López-Cano, JJ | 1 |
González-Cela-Casamayor, MA | 1 |
Andrés-Guerrero, V | 1 |
Herrero-Vanrell, R | 1 |
Benítez-Del-Castillo, JM | 1 |
Molina-Martínez, IT | 1 |
Adedara, IA | 1 |
Olabiyi, BF | 1 |
Ojuade, TD | 1 |
Idris, UF | 1 |
Onibiyo, EM | 1 |
Farombi, EO | 1 |
Nam, SY | 1 |
Kim, HM | 1 |
Jeong, HJ | 1 |
Galan, BS | 1 |
Carvalho, FG | 1 |
Santos, PC | 1 |
Gobbi, RB | 1 |
Kalva-Filho, CA | 1 |
Papoti, M | 1 |
da Silva, AS | 1 |
Freitas, EC | 1 |
Li, F | 1 |
Wu, J | 1 |
Wang, Y | 2 |
Yu, H | 2 |
Chan, SMH | 1 |
Lau, YS | 1 |
Miller, AA | 1 |
Ku, JM | 1 |
Potocnik, S | 1 |
Ye, JM | 1 |
Woodman, OL | 1 |
Herbert, TP | 1 |
Chupel, MU | 1 |
Minuzzi, LG | 1 |
Furtado, G | 1 |
Santos, ML | 1 |
Hogervorst, E | 1 |
Filaire, E | 1 |
Teixeira, AM | 1 |
Kim, W | 2 |
Jang, JH | 1 |
Kim, K | 2 |
Suh, YG | 2 |
Joe, Y | 2 |
Chung, HT | 2 |
Cha, YN | 3 |
Surh, YJ | 2 |
Pan, J | 1 |
Jin, R | 1 |
Wu, R | 1 |
Xu, S | 1 |
Zhao, W | 1 |
Jia, L | 1 |
Yang, HJ | 1 |
Xue, X | 1 |
Xu, WX | 1 |
Cai, JQ | 1 |
Guo, RJ | 1 |
Cao, CC | 1 |
Neary, PM | 1 |
Jinih, M | 1 |
O'Connell, E | 1 |
Foley, N | 1 |
Wang, JH | 1 |
O'Leary, DP | 1 |
Xiao, M | 1 |
Mi, Y | 1 |
Liu, L | 1 |
Lv, C | 1 |
Zeng, W | 1 |
Zhang, C | 1 |
Niu, X | 1 |
Zheng, S | 1 |
Liu, H | 1 |
Li, S | 1 |
Qiu, T | 2 |
Pei, P | 2 |
Yao, X | 2 |
Jiang, L | 2 |
Wei, S | 2 |
Bai, J | 1 |
Yang, G | 2 |
Gao, N | 2 |
Yang, L | 2 |
Qi, S | 1 |
Yan, R | 1 |
Sun, X | 2 |
Ghosh, S | 1 |
Chowdhury, S | 1 |
Das, AK | 1 |
Sil, PC | 2 |
Wang, N | 1 |
Liu, S | 1 |
Jia, X | 1 |
Tao, Y | 1 |
Zhou, J | 1 |
Yao, N | 1 |
Wang, S | 2 |
An, D | 1 |
Cao, K | 1 |
Wei, J | 1 |
Zhao, D | 1 |
Wang, L | 1 |
Chen, X | 1 |
Chiquita, S | 1 |
Ribeiro, M | 1 |
Castelhano, J | 1 |
Oliveira, F | 1 |
Sereno, J | 1 |
Batista, M | 1 |
Abrunhosa, A | 1 |
Rodrigues-Neves, AC | 1 |
Carecho, R | 1 |
Baptista, F | 1 |
Gomes, C | 1 |
Moreira, PI | 1 |
Ambrósio, AF | 1 |
Castelo-Branco, M | 1 |
Van Hove, JLK | 1 |
Freehauf, CL | 1 |
Ficicioglu, C | 1 |
Pena, LDM | 1 |
Moreau, KL | 1 |
Henthorn, TK | 1 |
Christians, U | 1 |
Jiang, H | 2 |
Cowan, TM | 1 |
Young, SP | 1 |
Hite, M | 1 |
Friederich, MW | 1 |
Stabler, SP | 1 |
Spector, EB | 1 |
Kronquist, KE | 1 |
Thomas, JA | 1 |
Emmett, P | 1 |
Harrington, MJ | 1 |
Pyle, L | 1 |
Creadon-Swindell, G | 1 |
Wempe, MF | 1 |
MacLean, KN | 2 |
Chen, DQ | 1 |
Cao, G | 1 |
Chen, H | 1 |
Argyopoulos, CP | 1 |
Su, W | 1 |
Chen, L | 1 |
Samuels, DC | 1 |
Zhuang, S | 1 |
Bayliss, GP | 1 |
Zhao, S | 1 |
Yu, XY | 1 |
Vaziri, ND | 1 |
Wang, M | 1 |
Mao, JR | 1 |
Ma, SX | 1 |
Zhao, J | 1 |
Shang, YQ | 1 |
Kang, H | 1 |
Ye, F | 1 |
Cheng, XH | 1 |
Li, XR | 1 |
Meng, MX | 1 |
Guo, Y | 1 |
Zhao, YY | 1 |
Manna, P | 1 |
Das, J | 1 |
Spreafico, A | 1 |
Millucci, L | 1 |
Ghezzi, L | 1 |
Geminiani, M | 1 |
Braconi, D | 1 |
Amato, L | 1 |
Chellini, F | 1 |
Frediani, B | 1 |
Moretti, E | 1 |
Collodel, G | 1 |
Bernardini, G | 1 |
Santucci, A | 1 |
Lin, S | 1 |
Hirai, S | 1 |
Yamaguchi, Y | 1 |
Goto, T | 1 |
Takahashi, N | 1 |
Tani, F | 1 |
Mutoh, C | 1 |
Sakurai, T | 1 |
Murakami, S | 1 |
Yu, R | 1 |
Kawada, T | 1 |
Dort, J | 1 |
Leblanc, N | 1 |
Maltais-Giguère, J | 1 |
Liaset, B | 1 |
Côté, CH | 1 |
Jacques, H | 1 |
Reynolds, CM | 1 |
Sloboda, DM | 1 |
Gray, C | 1 |
Vickers, MH | 1 |
Kim, KS | 1 |
Ji, HI | 1 |
Chung, H | 1 |
Lee, SH | 1 |
Lee, YA | 1 |
Yang, HI | 1 |
Yoo, MC | 1 |
Hong, SJ | 1 |
Velloso, MS | 1 |
Otoni, A | 1 |
de Paula Sabino, A | 1 |
de Castro, WV | 1 |
Pinto, SW | 1 |
Marinho, MA | 1 |
Rios, DR | 1 |
da Silva, LA | 1 |
Tromm, CB | 1 |
Bom, KF | 1 |
Mariano, I | 1 |
Pozzi, B | 1 |
da Rosa, GL | 1 |
Tuon, T | 1 |
da Luz, G | 1 |
Vuolo, F | 1 |
Petronilho, F | 1 |
Cassiano, W | 1 |
De Souza, CT | 1 |
Pinho, RA | 1 |
Latchoumycandane, C | 1 |
Nagy, LE | 1 |
McIntyre, TM | 1 |
Su, Y | 1 |
Fan, W | 1 |
Ma, Z | 1 |
Wen, X | 1 |
Wu, Q | 1 |
Huang, H | 1 |
Cardozo, C | 1 |
Donate, J | 1 |
Muros, M | 1 |
Pons, M | 1 |
Mensa, J | 1 |
Campistol, JM | 1 |
Navarro-González, JF | 1 |
Alhouayek, M | 1 |
Bottemanne, P | 1 |
Subramanian, KV | 1 |
Lambert, DM | 1 |
Makriyannis, A | 1 |
Cani, PD | 1 |
Muccioli, GG | 1 |
Zinellu, A | 1 |
Sotgia, S | 1 |
Mangoni, AA | 1 |
Sanna, M | 1 |
Satta, AE | 1 |
Carru, C | 1 |
Kim, HU | 1 |
Lee, HN | 1 |
Jang, J | 1 |
Jin, HO | 1 |
Lee, JK | 1 |
Walczewska, M | 3 |
Ciszek-Lenda, M | 1 |
Surmiak, M | 1 |
Kozlowska, A | 1 |
Jozefowski, S | 1 |
Marcinkiewicz, J | 9 |
Kato, T | 1 |
Okita, S | 1 |
Tsunekawa, M | 1 |
Ma, N | 1 |
Lin, CJ | 1 |
Chiu, CC | 1 |
Chen, YC | 1 |
Chen, ML | 1 |
Hsu, TC | 1 |
Tzang, BS | 1 |
Asahi, T | 1 |
Nakamura, Y | 1 |
Kato, Y | 1 |
Osawa, T | 1 |
Wu, F | 1 |
Koenig, KL | 1 |
Zeleniuch-Jacquotte, A | 1 |
Jonas, S | 1 |
Afanasyeva, Y | 1 |
Wójcik, OP | 1 |
Costa, M | 1 |
Ozsarlak-Sozer, G | 1 |
Sevin, G | 1 |
Ozgur, HH | 1 |
Yetik-Anacak, G | 1 |
Kerry, Z | 1 |
Reeta, KH | 1 |
Singh, D | 1 |
Gupta, YK | 1 |
Pupure, J | 1 |
Isajevs, S | 1 |
Gordjushina, V | 1 |
Taivans, I | 1 |
Rumaks, J | 1 |
Svirskis, S | 1 |
Kratovska, A | 1 |
Dzirkale, Z | 1 |
Pilipenko, J | 1 |
Duburs, G | 1 |
Klusa, V | 1 |
Yalçinkaya, S | 1 |
Unlüçerçi, Y | 1 |
Giriş, M | 1 |
Olgaç, V | 1 |
Doğru-Abbasoğlu, S | 1 |
Uysal, M | 1 |
Olszanecki, R | 2 |
Bobek, M | 3 |
Biedroń, R | 3 |
Dulak, J | 1 |
Józkowicz, A | 1 |
Kontny, E | 5 |
Maślinski, W | 4 |
Schuller-Levis, G | 3 |
Gordon, RE | 2 |
Wang, C | 1 |
Park, SY | 2 |
Park, E | 3 |
Nakajima, Y | 1 |
Osuka, K | 1 |
Seki, Y | 1 |
Gupta, RC | 1 |
Hara, M | 1 |
Takayasu, M | 1 |
Wakabayashi, T | 1 |
Kinsbourne, M | 1 |
Sun, M | 1 |
Zhao, Y | 1 |
Gu, Y | 1 |
Xu, C | 1 |
Kim, BS | 1 |
Cho, IS | 1 |
Levis, W | 1 |
Zheng, L | 1 |
Yu, X | 1 |
Zhu, W | 1 |
Zou, S | 1 |
Gentile, CL | 1 |
Nivala, AM | 1 |
Gonzales, JC | 1 |
Pfaffenbach, KT | 1 |
Wang, D | 1 |
Wei, Y | 1 |
Orlicky, DJ | 1 |
Petersen, DR | 1 |
Pagliassotti, MJ | 1 |
McPherson, RA | 1 |
Hardy, G | 1 |
Sternberg, Z | 1 |
Cesario, A | 1 |
Rittenhouse-Olson, K | 1 |
Sobel, RA | 1 |
Leung, YK | 1 |
Pankewycz, O | 1 |
Zhu, B | 1 |
Whitcomb, T | 1 |
Sternberg, DS | 1 |
Munschauer, FE | 1 |
Agackiran, Y | 1 |
Gul, H | 1 |
Gunay, E | 1 |
Akyurek, N | 1 |
Memis, L | 1 |
Gunay, S | 1 |
Sirin, YS | 1 |
Ide, T | 1 |
Devkota, S | 1 |
Musch, MW | 1 |
Leone, V | 1 |
Fehlner-Peach, H | 1 |
Nadimpalli, A | 1 |
Antonopoulos, DA | 1 |
Jabri, B | 1 |
Chang, EB | 1 |
de Rienzo-Madero, B | 1 |
Coffeen, U | 1 |
Simón-Arceo, K | 1 |
Mercado, F | 1 |
Jaimes, O | 1 |
Magis-Weinberg, L | 1 |
Contreras, B | 1 |
Pellicer, F | 1 |
Capuozzo, E | 1 |
Pecci, L | 1 |
Baseggio Conrado, A | 1 |
Fontana, M | 1 |
Olszowski, S | 1 |
Olszowska, E | 1 |
Kusior, D | 1 |
Szneler, E | 1 |
Osowska, S | 1 |
De Bandt, JP | 1 |
Chaïb, S | 1 |
Neveux, N | 1 |
Bérard, MP | 1 |
Cynober, L | 1 |
Miyamoto, Y | 1 |
Kanayama, A | 1 |
Inoue, J | 1 |
Konishi, YS | 1 |
Shimizu, M | 1 |
Wojtecka-Lukasik, E | 2 |
Marton, A | 1 |
Krajewska, K | 1 |
Burakowski, T | 1 |
Gujski, M | 2 |
Maslinska, D | 2 |
Maslinska, S | 1 |
Pennathur, S | 1 |
Bergt, C | 1 |
Shao, B | 1 |
Byun, J | 1 |
Kassim, SY | 1 |
Singh, P | 1 |
Green, PS | 1 |
McDonald, TO | 1 |
Brunzell, J | 1 |
Chait, A | 1 |
Oram, JF | 1 |
O'brien, K | 1 |
Geary, RL | 1 |
Heinecke, JW | 1 |
Mak, M | 1 |
Białecka, A | 1 |
Koprowski, M | 1 |
Stuckey, DJ | 1 |
Anthony, DC | 1 |
Lowe, JP | 1 |
Miller, J | 1 |
Palm, WM | 1 |
Styles, P | 1 |
Perry, VH | 1 |
Blamire, AM | 1 |
Sibson, NR | 1 |
Czuprynska, K | 1 |
Gajewski, M | 1 |
Maslinski, S | 1 |
Grimble, RF | 1 |
Cantin, AM | 1 |
Berthiaume, Y | 1 |
Cloutier, D | 1 |
Martel, M | 1 |
Ward, R | 1 |
Cirkovic-Vellichovia, T | 1 |
Ledeque, F | 1 |
Tirizitis, G | 1 |
Dubars, G | 1 |
Datla, K | 1 |
Dexter, D | 1 |
Heushling, P | 1 |
Crichton, R | 1 |
Kurnyta, M | 1 |
Quinn, MR | 1 |
Wright, CE | 1 |
Stapleton, PP | 3 |
Mahon, TM | 1 |
Nowlan, P | 1 |
Bloomfield, FJ | 2 |
Bouchier-Hayes, DJ | 1 |
Ying, QL | 1 |
Kemme, M | 1 |
Saunders, D | 1 |
Simon, SR | 1 |
Chung, JK | 1 |
Jeong, JM | 1 |
Chang, YS | 1 |
Lee, YJ | 1 |
Kim, YJ | 1 |
Lee, MC | 1 |
Koh, CS | 1 |
Kim, BK | 1 |
Vile, GF | 1 |
Rothwell, LA | 1 |
Kettle, AJ | 1 |
Wheeler, MD | 1 |
Ikejema, K | 1 |
Enomoto, N | 1 |
Stacklewitz, RF | 1 |
Seabra, V | 1 |
Zhong, Z | 1 |
Yin, M | 1 |
Schemmer, P | 1 |
Rose, ML | 1 |
Rusyn, I | 1 |
Bradford, B | 1 |
Thurman, RG | 1 |
Esquifino, AI | 1 |
García Bonacho, M | 1 |
Arce, A | 1 |
Cutrera, RA | 1 |
Cardinali, DP | 1 |
Wang, Q | 1 |
Hyde, DM | 1 |
Giri, SN | 1 |
McLoughlin, DM | 1 |
Grisham, MB | 1 |
Gaginella, TS | 1 |
von Ritter, C | 1 |
Tamai, H | 1 |
Be, RM | 1 |
Granger, DN | 1 |
Severns, C | 1 |
Collins-Lech, C | 1 |
Sohnle, PG | 1 |
Shaked, AA | 1 |
Solano, DF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
Taurine as a Possible Anti-aging Therapy? A Controlled Clinical Trial on Taurine Antioxidant Activity in Women Aged 55 to 70 Years[NCT05149716] | 24 participants (Actual) | Interventional | 2020-01-13 | Completed | |||
Evaluation of the Capability of a Glycine Oral Supplement for Diminishing Bronchial Inflammation in Children With Cystic Fibrosis[NCT01417481] | Phase 2 | 13 participants (Actual) | Interventional | 2012-03-31 | Terminated (stopped due to Some of the researchers finished their participation in the study.) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentages were log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
Intervention | log (percent change) (Mean) |
---|---|
Glycine | -0.3908 |
Placebo | 0.2035 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentage change was log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
Intervention | log (percent change) (Mean) |
---|---|
Glycine | -0.0819 |
Placebo | 0.1668 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentage change was log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
Intervention | log (percent change) (Mean) |
---|---|
Glycine | -0.00007 |
Placebo | 0.1739 |
"To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]).~Each respiratory symptom (Cough severity, Sputum features, Appetite, Dyspnea, and Energy perception) was evaluated in a 5-options Likert scale, ranging from 1 (better) to 5 (worse). The total score was computed by the simple sum of the five symptoms." (NCT01417481)
Timeframe: 8 weeks
Intervention | Percentage of baseline (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Cough questionnaire score | Appetite questionnaire score | Energy questionnaire score | Body weight | Height | Heart rate | Respiratory rate | Temperature | |
Glycine | 81.1 | 89.1 | 84.6 | 101.6 | 100.5 | 103.5 | 94.8 | 100.0 |
Placebo | 89.1 | 132.1 | 111.5 | 103.6 | 100.5 | 98.1 | 109.0 | 100.1 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). (NCT01417481)
Timeframe: 8 weeks
Intervention | Percentage of baseline (Mean) | ||
---|---|---|---|
Forced expiratory volume at first second (FEV1) | Forced expiratory flow at 25%FVC (FEF25) | Maximal forced expiratory flow (FEFmax, PEFR) | |
Glycine | 109.7 | 133.9 | 115.3 |
Placebo | 91.4 | 83.3 | 91.2 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). (NCT01417481)
Timeframe: 8 weeks
Intervention | Percentage of baseline (Mean) | |
---|---|---|
Forced vital capacity (FVC) | Forced expiratory flow at 75%FVC (FEF75) | |
Glycine | 104.1 | 111.8 |
Placebo | 100.6 | 108.9 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). (NCT01417481)
Timeframe: 8 weeks
Intervention | Percentage of baseline (Mean) | ||
---|---|---|---|
Peripheral oxygen saturation (SpO2) | FEV1/FVC | Forced expiratory flow at 50%FVC (FEF50) | |
Glycine | 105.2 | 105.2 | 115.5 |
Placebo | 98.9 | 94.9 | 93.1 |
"To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]).~In the symptoms questionnaire, each respiratory symptom (Cough severity, Sputum features, Appetite, Dyspnea, and Energy perception) was evaluated in a 5-options Likert scale, ranging from 1 (better) to 5 (worse). The total score was computed by the simple sum of the five symptoms." (NCT01417481)
Timeframe: 8 weeks
Intervention | Percentage of baseline (Mean) | ||
---|---|---|---|
Sputum questionnaire score | Dyspnea questionnaire score | Total questionnaire score | |
Glycine | 82.0 | 75.6 | 77.7 |
Placebo | 102.6 | 103.8 | 98.7 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentages were log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
Intervention | log (percent change) (Mean) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Myeloperoxidase | IL-1 | IL-4 | IL-6 | IL-7 | IL-8 | IL-12 | IL-13 | G-CSF | IFN-gamma | MCP-1 | MIP-1beta | |
Glycine | -0.4361 | -0.1635 | 0.2964 | 0.0085 | 0.0356 | -0.1466 | 0.3203 | -0.0561 | -0.0776 | 0.3272 | -0.0836 | 0.0330 |
Placebo | -0.2906 | -0.0352 | 0.1470 | 0.2255 | 0.0819 | -0.2364 | 0.2603 | 0.1953 | 0.2272 | 0.3639 | 0.0472 | -0.0608 |
To correct for the baseline variability, all measurements were expressed as percentage of baseline (value at week 8 with respect to baseline value [beginning of the glycine or placebo period, respectively]). Then, percentage change was log-transformed to adjust to a normal distribution. (NCT01417481)
Timeframe: 8 weeks
Intervention | log (percent change) (Mean) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Myeloperoxidase | IL-1 | IL-2 | IL-4 | IL-5 | IL-7 | IL-8 | IL-10 | IL-12 | IL-13 | IL-17 | IFN-gamma | MCP-1 | MIP-1beta | TNF-alpha | GM-CSF | |
Glycine | 0.1294 | -0.0918 | 0.0233 | -0.0161 | 0.2498 | 0.0611 | -0.0824 | 0.0549 | 0.1675 | 0.1630 | 0.0680 | 0.0248 | 0.0042 | -0.0303 | 0.0412 | -0.0538 |
Placebo | 0.0669 | -0.0102 | -0.0274 | 0.0522 | 0.1304 | 0.1387 | 0.0542 | 0.0074 | 0.0677 | 0.0953 | 0.1140 | 0.0649 | 0.2608 | 0.0977 | 0.1568 | -0.0822 |
15 reviews available for taurine and Innate Inflammatory Response
Article | Year |
---|---|
Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.
Topics: Biomarkers; C-Reactive Protein; Dietary Supplements; Humans; Inflammation; Interleukin-6; Oxidative | 2022 |
Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal | 2020 |
The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Inflammation; Obesity; Taurine | 2020 |
The molecular targets of taurine confer anti-hyperlipidemic effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Autophagy; Cholesterol; Cholesterol 7-alpha-Hydroxy | 2021 |
Taurine in sports and exercise.
Topics: Athletic Performance; Blood Glucose; Body Temperature Regulation; Calcium; Dietary Supplements; Ener | 2021 |
Role of sulfur containing amino acids as an adjuvant therapy in the prevention of diabetes and its associated complications.
Topics: 3T3-L1 Cells; Amino Acids, Sulfur; Animals; Blood Glucose; Cells, Cultured; Cysteine; Diabetes Melli | 2013 |
Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects.
Topics: Animals; Antioxidants; Apoptosis; Chronic Disease; Cytoprotection; Humans; Inflammation; Inflammatio | 2014 |
Peritoneal dialysis and inflammation.
Topics: Dialysis Solutions; Glucans; Glucose; Humans; Hydrogen-Ion Concentration; Icodextrin; Inflammation; | 2014 |
Taurine bromamine (TauBr)--its role in immunity and new perspectives for clinical use.
Topics: Acne Vulgaris; Anti-Infective Agents; Anti-Inflammatory Agents; Clinical Trials as Topic; Eosinophil | 2010 |
Clinical and nutritional benefits of cysteine-enriched protein supplements.
Topics: Antioxidants; Cysteine; Dietary Supplements; Functional Food; Glutathione; Humans; Inflammation; Ker | 2011 |
[Taurine chloramine and its potential therapeutical application].
Topics: Animals; Humans; Inflammation; Inflammation Mediators; Taurine | 2011 |
Taurine and inflammatory diseases.
Topics: Animals; Anti-Infective Agents; Apoptosis; Arthritis, Rheumatoid; Bile Acids and Salts; Calcium; Hum | 2014 |
The effects of sulfur amino acid intake on immune function in humans.
Topics: Amino Acids, Sulfur; Animals; Diet; Dose-Response Relationship, Drug; Glutathione; Homocysteine; Hum | 2006 |
Taurine and inflammation--a new approach to an old problem?
Topics: Animals; Humans; Inflammation; Taurine | 1997 |
Glycine: a new anti-inflammatory immunonutrient.
Topics: Alcohols; Animals; Anti-Inflammatory Agents; Calcium Channels, L-Type; Chloride Channels; Cyclospori | 1999 |
7 trials available for taurine and Innate Inflammatory Response
Article | Year |
---|---|
Dietary taurine supplementation attenuates lipopolysaccharide-induced inflammatory responses and oxidative stress of broiler chickens at an early age.
Topics: Animal Feed; Animals; Antioxidants; Chickens; Cytokines; Diet; Dietary Supplements; Gene Expression | 2020 |
Effects of taurine on markers of muscle damage, inflammatory response and physical performance in triathletes.
Topics: Adult; Athletic Performance; Bicycling; Biomarkers; Creatine Kinase; Cross-Over Studies; Dietary Sup | 2018 |
Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood-Brain Barrier; Cognition; Cytokines; Exercise; Female; Fo | 2018 |
RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Biomarkers; Chemotherapy, Adjuvant; Colectomy | 2018 |
Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine β-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial.
Topics: Adolescent; Adult; Biomarkers; Brachial Artery; Child; Cystathionine beta-Synthase; Female; Homocyst | 2019 |
Effects of taurine supplementation following eccentric exercise in young adults.
Topics: Dietary Supplements; Exercise; Humans; Inflammation; Male; Muscle, Skeletal; Oxidative Stress; Tauri | 2014 |
Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Topics: Aged; Allantoin; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Res | 2015 |
96 other studies available for taurine and Innate Inflammatory Response
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Taurine protects blood-milk barrier integrity via limiting inflammatory response in Streptococcus uberis infections.
Topics: Animals; Female; Inflammation; Mastitis; Mice; Mice, Inbred C57BL; Milk; Random Allocation; Specific | 2021 |
GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease.
Topics: Bacteria; Betaine; Colitis, Ulcerative; Crohn Disease; Genome-Wide Association Study; Humans; Inflam | 2022 |
Effects of taurine and apocynin on the zone of stasis.
Topics: Animals; Antioxidants; Burns; Disease Models, Animal; Inflammation; Rats; Rats, Sprague-Dawley; Taur | 2022 |
Mechanism of taurine reducing inflammation and organ injury in sepsis mice.
Topics: Animals; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neutrophils; Sepsis; Taurine; | 2022 |
Synergism Between Taurine and Dexamethasone in Anti-inflammatory Response in LPS-Activated Macrophages.
Topics: Anti-Inflammatory Agents; Cytokines; Dexamethasone; Humans; Inflammation; Lipopolysaccharides; Macro | 2022 |
Taurine Chloramine Inhibits Leukocyte Migration by Suppressing Actin Polymerization and Extracellular Signal-Regulated Kinase.
Topics: Actins; Animals; Extracellular Signal-Regulated MAP Kinases; Inflammation; Lipopolysaccharides; Mamm | 2022 |
Taurine inhibits hydrogen peroxide-induced oxidative stress, inflammatory response and apoptosis in liver of Monopterus albus.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Beclin-1; Environmental Biomarkers; Hy | 2022 |
Metabonomics profile analysis in inflammation-induced preterm birth and the potential role of metabolites in regulating premature cervical ripening.
Topics: Animals; Cervical Ripening; Female; Humans; Infant, Newborn; Inflammation; Mice; Mice, Inbred C57BL; | 2022 |
Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.
Topics: Animals; Antioxidants; Bile Ducts; Cholestasis; Fibrosis; Inflammation; Ligation; Liver; Liver Cirrh | 2022 |
Dietary taurine supplementation counteracts deoxynivalenol-induced liver injury via alleviating oxidative stress, mitochondrial dysfunction, apoptosis, and inflammation in piglets.
Topics: Animal Feed; Animals; Antioxidants; Apoptosis; Chemical and Drug Induced Liver Injury, Chronic; Diet | 2023 |
Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients - identification of patient subsets with increased transplant-related mortality.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Leukemia, Myel | 2023 |
The protective effect of taurine on cyclophosphamide-induced testicular toxicity in rats.
Topics: Animals; Antioxidants; Cyclophosphamide; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-D | 2023 |
Taurine modulates hepatic oxidative status and gut inflammatory markers of European seabass (Dicentrarchus labrax) fed plant feedstuffs-based diets.
Topics: Animal Feed; Animals; Antioxidants; Apoptosis; Bass; Caspase 3; Caspase 9; Diet; Glucosephosphate De | 2019 |
Ribose-Taurine Suppresses Inflammation Through NF-κB Regulation in Activated RAW 264.7 Macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Cytokines; Dinoprostone; Inflammation; Lipopoly | 2019 |
Emodin relieved lipopolysaccharide-evoked inflammatory damage in WI-38 cells by up-regulating taurine up-regulated gene 1.
Topics: Apoptosis; Cell Line; Cell Survival; Chemokine CCL2; Emodin; Humans; Inflammation; Interleukin-6; Li | 2020 |
Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells.
Topics: Adenylate Kinase; Animals; Apoptosis; Cell Cycle Proteins; Cell Line; Cell Survival; Dexmedetomidine | 2020 |
Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Biofilms; Catheter-Related In | 2021 |
Taurine Attenuates Catabolic Processes Related to the Onset of Sarcopenia.
Topics: Aging; Amino Acids; Animals; Antioxidants; Autophagy; Gene Expression Regulation, Developmental; Hum | 2020 |
Dietary taurine modulates hepatic oxidative status, ER stress and inflammation in juvenile turbot (Scophthalmus maximus L.) fed high carbohydrate diets.
Topics: Animal Feed; Animals; Diet; Diet, Carbohydrate Loading; Dietary Supplements; Dose-Response Relations | 2021 |
The role of taurine derivatives in the putative therapy of COVID-19-induced inflammation.
Topics: COVID-19; Humans; Inflammation; SARS-CoV-2; Taurine | 2022 |
Taurine Alleviates Sympathetic Innervation by Inhibiting NLRP3 Inflammasome in Postinfarcted Rats.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Inflammasomes; Inflammation; Interleukin- | 2021 |
The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Apoptosis; Blood Urea Nitrogen; Creatinine; Dose-Response | 2021 |
Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments.
Topics: Animals; Apoptosis; Betaine; Carnitine; Cell Survival; Cells, Cultured; Dry Eye Syndromes; Epitheliu | 2021 |
Taurine reverses sodium fluoride-mediated increase in inflammation, caspase-3 activity, and oxidative damage along the brain-pituitary-gonadal axis in male rats.
Topics: Animals; Biomarkers; Body Weight; Brain; Caspase 3; Epididymis; Inflammation; Male; Oxidative Stress | 2017 |
The potential protective role of taurine against experimental allergic inflammation.
Topics: Animals; Caspase 1; Cell Line; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; | 2017 |
Taurine alleviates lipopolysaccharide‑induced liver injury by anti‑inflammation and antioxidants in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced | 2017 |
Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response.
Topics: Angiotensin II; Animals; Cell Line, Tumor; Cytokines; Diabetes Mellitus, Type 2; eIF-2 Kinase; Endop | 2017 |
Role of heme oxygenase-1 in potentiation of phagocytic activity of macrophages by taurine chloramine: Implications for the resolution of zymosan A-induced murine peritonitis.
Topics: Animals; Antioxidants; Heme Oxygenase-1; Inflammation; Macrophages; Macrophages, Peritoneal; Mice; M | 2018 |
Acamprosate Protects Against Adjuvant-Induced Arthritis in Rats via Blocking the ERK/MAPK and NF-κB Signaling Pathway.
Topics: Acamprosate; Animals; Arthritis, Experimental; Inflammation; Male; MAP Kinase Signaling System; NF-k | 2018 |
Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system.
Topics: Acute Lung Injury; Animals; Apoptosis; Caspase 3; Dexmedetomidine; Immune System; Inflammation; Ki-6 | 2018 |
Taurine regulates mucosal barrier function to alleviate lipopolysaccharide-induced duodenal inflammation in chicken.
Topics: Animals; Chickens; Duodenitis; Duodenum; Inflammation; Intestinal Mucosa; Lipopolysaccharides; Poult | 2018 |
Protective effects of taurine against inflammation, apoptosis, and oxidative stress in brain injury.
Topics: Acetylcholinesterase; Animals; Antioxidants; Apoptosis; Astrocytes; bcl-2-Associated X Protein; Brai | 2018 |
Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway.
Topics: Animals; Arsenic; Autophagy; Cell Survival; Hep G2 Cells; Humans; Inflammation; Mice; Mice, Inbred C | 2018 |
Taurine ameliorates oxidative stress induced inflammation and ER stress mediated testicular damage in STZ-induced diabetic Wistar rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Catalase; Chemokines; Diabet | 2019 |
Inorganic arsenic induces pyroptosis and pancreatic β cells dysfunction through stimulating the IRE1α/TNF-α pathway and protective effect of taurine.
Topics: Animals; Anti-Inflammatory Agents; Arsenic Trioxide; Cell Line, Tumor; Endoplasmic Reticulum Stress; | 2019 |
Fructus Gardeniae-induced gastrointestinal injury was associated with the inflammatory response mediated by the disturbance of vitamin B6, phenylalanine, arachidonic acid, taurine and hypotaurine metabolism.
Topics: Animals; Arachidonic Acid; Chromatography, High Pressure Liquid; Gardenia; Gastrointestinal Diseases | 2019 |
A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Blood-Brain Barrier; Disease Models, | 2019 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea | 2019 |
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.
Topics: Acetylcysteine; Alkaptonuria; Antioxidants; Ascorbic Acid; Cell Line; Chondrocytes; Cytokines; Human | 2013 |
Taurine improves obesity-induced inflammatory responses and modulates the unbalanced phenotype of adipose tissue macrophages.
Topics: Adipose Tissue; Animals; Bone Marrow Cells; Cytokines; Diet, High-Fat; Hyperglycemia; Inflammation; | 2013 |
Beneficial effects of cod protein on inflammatory cell accumulation in rat skeletal muscle after injury are driven by its high levels of arginine, glycine, taurine and lysine.
Topics: Amino Acids; Animals; Arginine; Cyclooxygenase 2; Dietary Proteins; Eating; Fish Proteins; Gadiforme | 2013 |
Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity.
Topics: Animals; Animals, Newborn; Biomarkers; Body Weight; Dietary Supplements; Disease Models, Animal; Fem | 2013 |
Taurine chloramine modulates the expression of adipokines through inhibition of the STAT-3 signaling pathway in differentiated human adipocytes.
Topics: Adipocytes; Adipokines; Cell Differentiation; Cells, Cultured; Humans; Inflammation; Signal Transduc | 2013 |
Chronic ethanol ingestion induces oxidative kidney injury through taurine-inhibitable inflammation.
Topics: Acute Kidney Injury; Animals; Antioxidants; Cytochrome P-450 CYP2E1; Ethanol; Free Radicals; Humans; | 2014 |
Taurine improves functional and histological outcomes and reduces inflammation in traumatic brain injury.
Topics: Animals; Brain Injuries; Disease Models, Animal; Fluorescent Antibody Technique; Inflammation; Male; | 2014 |
Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; C-Reactive Protein; Catheter- | 2014 |
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Chromatography, High | 2015 |
Taurine Chloramine Stimulates Efferocytosis Through Upregulation of Nrf2-Mediated Heme Oxygenase-1 Expression in Murine Macrophages: Possible Involvement of Carbon Monoxide.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carbon Monoxide; Cytoskeletal Proteins; Disease Model | 2015 |
Impact of Taurine on Innate and Adaptive Immunity as the Result of HOCl Neutralization.
Topics: Adaptive Immunity; Albumins; alpha 1-Antitrypsin; Animals; Antibody Formation; Hypochlorous Acid; Im | 2015 |
The effects of taurine administration against inflammation in heavily exercised skeletal muscle of rats.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Drinking; Eating; Inflammation; In | 2015 |
Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling.
Topics: Animals; C-Reactive Protein; Chemical and Drug Induced Liver Injury; Ethanol; Inflammation; Inflamma | 2015 |
Specific role of taurine in the 8-brominated-2'-deoxyguanosine formation.
Topics: Animals; Bromates; Chromatography, High Pressure Liquid; Deoxyguanosine; Halogenation; Humans; Hypoc | 2015 |
Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antioxidants; Bile Acids and Salts; Blood Pressure; Case-Cont | 2016 |
Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits.
Topics: Acetylcholine; Animals; Aorta; Buthionine Sulfoximine; Carotid Arteries; Glutathione; Immunohistoche | 2016 |
Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation.
Topics: Animals; Choline O-Acetyltransferase; Cognitive Dysfunction; Drug Administration Schedule; Inflammat | 2017 |
Distinct influence of atypical 1,4-dihydropyridine compounds in azidothymidine-induced neuro- and cardiotoxicity in mice ex vivo.
Topics: Animals; Anti-HIV Agents; Apoptosis; Caspase 3; Cerebral Cortex; Dihydropyridines; Gene Expression R | 2008 |
Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine.
Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; bcl-2-Associate | 2009 |
Taurine haloamines and heme oxygenase-1 cooperate in the regulation of inflammation and attenuation of oxidative stress.
Topics: Animals; Carbon Monoxide; Cytokines; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Inflammation; | 2009 |
Protection of bleomycin-induced fibrosis and inflammation by taurine.
Topics: Animals; Bleomycin; Cell Movement; Chemotaxis; Chromatography, High Pressure Liquid; Cytoprotection; | 2009 |
Taurine reduces inflammatory responses after spinal cord injury.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cyclooxygenase 2; Enzyme-Linked Immunosorbent | 2010 |
The Immune system's moderating response to inflammation relieves autistic behavior: response to Peter Good.
Topics: Autistic Disorder; Child; Cytokines; Humans; Immune System; Inflammation; Parasympathetic Nervous Sy | 2011 |
Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Death; Disease Models, Animal; Gene Expression Regula | 2012 |
Taurine chloramine inhibits NO and TNF-α production in zymosan plus interferon-γ activated RAW 264.7 cells.
Topics: Animals; Blotting, Western; Dose-Response Relationship, Drug; Inflammation; Interferon-gamma; Macrop | 2011 |
Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells.
Topics: Acetylglucosaminidase; Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4 Lymphocyte Count; Disea | 2012 |
Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.
Topics: Animals; Cell Death; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Diet; Endoplasmic Ret | 2011 |
Acamprosate modulates experimental autoimmune encephalomyelitis.
Topics: Acamprosate; Animals; Blood-Brain Barrier; Body Weight; Demyelinating Diseases; Encephalomyelitis, A | 2012 |
The efficiency of proanthocyanidin in an experimental pulmonary fibrosis model: comparison with taurine.
Topics: Animals; Antioxidants; Bleomycin; Grape Seed Extract; Hydroxyproline; Inflammation; Lung; Lymphocyte | 2012 |
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice.
Topics: Animals; Bile Acids and Salts; Bilophila; Colitis; Diet, Fat-Restricted; Dietary Fats; Inflammation; | 2012 |
Taurine enhances antinociception produced by a COX-2 inhibitor in an inflammatory pain model.
Topics: Analgesics; Animals; Carrageenan; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Synergism; Drug Thera | 2013 |
Thiotaurine prevents apoptosis of human neutrophils: a putative role in inflammation.
Topics: Apoptosis; Caspase 3; Caspase Inhibitors; Cytoprotection; Glutathione; Humans; Inflammation; Neutrop | 2013 |
Sulphoacetaldehyde as a product of taurine chloramine peroxidation at site of inflammation.
Topics: Acetaldehyde; Chromatography, High Pressure Liquid; Horseradish Peroxidase; Hydrogen Peroxide; Infla | 2002 |
Efficiency of a cysteine-taurine-threonine-serine supplemented parenteral nutrition in an experimental model of acute inflammation.
Topics: Acute Disease; Animals; Cysteine; Dietary Supplements; Inflammation; Male; Parenteral Nutrition; Pro | 2003 |
Anti-inflammatory activities of taurine chloramine: implication for immunoregulation and pathogenesis of rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Humans; Inflammation; | 2003 |
Taurine is involved in oxidation of IkappaB alpha at Met45: N-halogenated taurine and anti-inflammatory action.
Topics: Animals; Humans; I-kappa B Proteins; Inflammation; Jurkat Cells; Methionine; NF-KappaB Inhibitor alp | 2003 |
Taurine chloramine modifies carrageenin- and casein-induced inflammation in the rat.
Topics: Animals; Carrageenan; Caseins; Inflammation; Inflammation Mediators; Male; Neutrophils; Rats; Rats, | 2004 |
Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.
Topics: Arteries; Arteriosclerosis; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, D | 2004 |
Taurine chloramine and taurine bromamine induce heme oxygenase-1 in resting and LPS-stimulated J774.2 macrophages.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cell Line; Cell Survival; Dose-Response Relati | 2004 |
Is there a role of taurine bromamine in inflammation? Interactive effects with nitrite and hydrogen peroxide.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Cytokines; Drug Interactions; Drug Stability; Hydro | 2005 |
Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy.
Topics: Amino Acids; Animals; Biomarkers; Brain Injuries; Cell Communication; Cell Extracts; Cell Line; Cell | 2005 |
Taurine-chloramine is a potent antiinflammatory substance.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Histamine; Inflammation; Male; Rats; Rea | 2006 |
Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; alpha 1-Antitrypsin; Cystic Fibrosis; Female; Humans; | 2006 |
Accumulation of taurine in tumor and inflammatory lesions.
Topics: Animals; Cell Line; Inflammation; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; N | 2006 |
Neuroprotection by taurine and taurine analogues.
Topics: Animals; Antioxidants; Catalase; Cell Line; Free Radical Scavengers; Glutathione; Inflammation; Live | 2006 |
Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chloramines; Enzyme Induction; Heme Oxygenase-1; | 2006 |
Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells.
Topics: Amino Acid Oxidoreductases; Animals; Biological Transport; Cell Line; Inflammation; Interferon-gamma | 1993 |
Effects of in-vivo administration of taurine and HEPES on the inflammatory response in rats.
Topics: Animals; Carrageenan; Drug Administration Routes; Edema; Female; Half-Life; HEPES; Inflammation; Inj | 1994 |
Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor.
Topics: Glycosaminoglycans; Heparin; Humans; Inflammation; Kinetics; Leukocyte Elastase; Oxidation-Reduction | 1997 |
Uptake of taurine and taurine chloramine in murine macrophages and their distribution in mice with experimental inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Humans; Inflammation; Macrophages | 1998 |
Initiation of rapid, P53-dependent growth arrest in cultured human skin fibroblasts by reactive chlorine species.
Topics: Cell Division; Cell Survival; Cells, Cultured; Chloramines; Cyclin-Dependent Kinase Inhibitor p21; C | 2000 |
Age-dependent changes in 24-hour rhythms of thymic and circulating growth hormone and adrenocorticotropin in rats injected with Freund's adjuvant.
Topics: Adrenocorticotropic Hormone; Aging; Animals; Aspartic Acid; Behavior, Animal; Chronobiology Disorder | 2001 |
Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Membrane Permeability; Cricetinae; Drug Thera | 1992 |
Influence of taurine and a substituted taurine on the respiratory burst pathway in the inflammatory response.
Topics: Calcimycin; Dinoprostone; HEPES; Humans; Inflammation; Leukotriene B4; Luminescent Measurements; Neu | 1991 |
Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability.
Topics: Animals; Body Water; Cell Membrane Permeability; Chloramines; Edetic Acid; Electrolytes; Epithelium; | 1990 |
Effect of temperature on production of hypochlorous acid by stimulated human neutrophils.
Topics: Cell Survival; Horseradish Peroxidase; Humans; Hydrogen Peroxide; Hypochlorous Acid; In Vitro Techni | 1986 |
Taurine protects hamster bronchioles from acute NO2-induced alterations. A histologic, ultrastructural, and freeze-fracture study.
Topics: Animals; Bronchi; Cricetinae; Freeze Fracturing; Guinea Pigs; Horseradish Peroxidase; Inflammation; | 1986 |